Skip to content Skip to footer

CBD Market Overview: Europe 2025

CBD Market Overview: Europe 2025
Share this story

The European CBD market continues to operate under a fragmented and inconsistent regulatory landscape, with tolerance levels varying significantly by country. While some governments have adopted progressive frameworks allowing low-THC hemp products across food, cosmetics, and vape segments, others maintain restrictive interpretations under narcotics and novel food laws.

The EU Novel Food Regulation remains the central barrier to the ingestion of CBD products. As of 2025, no CBD product has received full EU authorisation as a novel food, creating widespread legal uncertainty for ingestible products. In contrast, topical and cosmetic formulations—subject to cosmetic safety and labelling laws—are widely tolerated.

Several markets, including Switzerland, Austria, and the Czech Republic, have introduced more liberal domestic regimes, while Italy, Ireland, and Finland continue to enforce strict measures limiting or criminalising CBD products that contain any trace of THC.

Below is a summary of CBD market tolerance levels and regulatory positions across key European countries.

Ireland

Tolerance: Low
CBD food supplements and ingestible oils are regulated by the Food Safety Authority of Ireland (FSAI) and must obtain Novel Food authorisation—none have been approved.
Cosmetic CBD products are available, but ingestibles and flowers operate in a grey market.
The government maintains active enforcement, with raids and product seizures continuing. In 2024, a High Court challenge seeking approval for non-intoxicating CBD with trace THC was dismissed.

United Kingdom

Tolerance: High
The UK hosts one of Europe’s largest CBD markets, despite persistent regulatory ambiguity.
The Food Standards Agency (FSA) continues reviewing Novel Food applications, with limited progress toward final approvals.
Import disruptions persist as the Home Office seizes products containing trace THC, though court challenges from businesses are ongoing.

Portugal

Tolerance: Low
Portugal’s CBD sector remains small and under-regulated.
Authorities make no clear distinction between hemp-derived and cannabis-derived CBD.
CBD stores operate informally, but are subject to raids and confiscations, including cosmetic removals ordered by health authorities in February 2025.

Spain

Tolerance: Medium
Spain’s CBD market, particularly in Barcelona, is active but precarious.
Authorities continue to crack down on grey-market operators, seizing oils and flowers that exceed unclear THC thresholds.
Only cosmetic products are officially recognised as legitimate by regulators.

France

Tolerance: Medium
France’s initial tolerance has been replaced by regulatory caution, with both the ANSM (medicines agency) and ANSES (food authority) citing potential health and fertility risks linked to CBD.
In September 2024, France submitted an EU-level proposal to ban CBD based on reproductive toxicity concerns.
Despite this, enforcement against domestic CBD sales remains limited.

Belgium

Tolerance: Medium
Since April 2019, Belgium has formally regulated CBD flower cigarettes below 0.2% THC.
CBD oils and cosmetics are widely available, though store raids occasionally occur.

Luxembourg

Tolerance: High
CBD and hemp with up to 1% THC are permitted as tobacco substitutes, taxed and regulated accordingly.
CBD cosmetics are legal, though ingestibles remain subject to Novel Food restrictions.

Netherlands

Tolerance: Medium
CBD products are legal under 0.05% THC, widely available in retail, pharmacy, and online outlets.
While hemp cultivation is permitted, CBD extraction is prohibited, leading to reliance on imported extracts.
Ingestibles remain governed by Novel Food law.

Switzerland

Tolerance: Very High
Switzerland maintains one of Europe’s most advanced CBD markets, allowing up to 1% THC in products.
CBD items—flowers, vapes, oils, cosmetics—are regulated by product category under the Federal Office of Public Health (FOPH) and Federal Food Safety & Veterinary Office (FSVO).
CBD may not be marketed for pharmacological effects, but operates in a fully legal, multi-sector market.

Italy

Tolerance: Low
The CBD industry remains volatile due to shifting government policy.
In April 2025, the government enacted an emergency decree classifying all hemp flower as a narcotic, pending parliamentary approval.
If confirmed, this measure could criminalise thousands of businesses.
Legal challenges are anticipated at national and EU levels.

Germany

Tolerance: Medium
Germany’s CBD market remains constrained by the ‘intoxication clause’, which treats low-THC hemp as potentially narcotic.
The proposed Industrial Hemp Liberalisation Act (NLG)—intended to remove this clause and permit indoor cultivation and sale of hemp flower—was delayed due to the 2024 snap election.
Authorities continue seizures and prosecutions, though farmers’ groups back reform.

Denmark

Tolerance: Medium
CBD cosmetics are legal, but ingestibles are classified as medicines.
CBD flower and resin are sold as aromatherapy or collectibles to bypass restrictions.

Austria

Tolerance: High
The CBD market is well established, bolstered by a January 2025 court ruling clarifying that hemp flower under 0.3% THC is taxable as a tobacco product (34%) and can only be sold in licensed tobacco shops.
CBD oils and cosmetics remain widely sold.

Slovenia

Tolerance: Low
Only synthetic CBD is approved for use in cosmetics; plant-derived CBD is prohibited.
Foods and supplements require Novel Food authorisation.

Malta

Tolerance: Medium
Following the 2021 Cannabis Reform Act, CBD products—oils, cosmetics, supplements—are widely available.
However, CBD flowers remain prohibited, and criminal proceedings have been brought against importers and clinics for sales or purchases.

Czech Republic

Tolerance: Very High
The Czech Republic leads in CBD and alternative cannabinoid regulation.
It allows hemp cultivation up to 1% THC, and the Psychomodulatory Substances Act (effective July 2025) introduces regulated retail for CBD and low-THC products.
Retailers must ensure adult-only sales and product-quality verification.

Poland

Tolerance: Medium
Authorities continue raids on CBD flower retailers amid legal uncertainty.
CBD oils remain tolerated, but new laws may classify flower as narcotic.

Slovakia

Tolerance: Low
Only synthetic CBD in cosmetics is legal.
Plant-derived CBD in food or supplements remains unauthorised under Novel Food rules.

Hungary

Tolerance: Medium
CBD cosmetics are legal, but flowers and oils sold as ‘not for consumption’ remain vulnerable to criminal proceedings.
Products must have THC below 0.2%.

Croatia

Tolerance: Medium
CBD products are widely available in retail and specialty stores—flowers, oils, resins, vapes, cosmetics, supplements.

Romania

Tolerance: Medium
Only THC-free (isolate-based) CBD products are legal.
CBD oils, vapes, and cosmetics are available in pharmacies and beauty stores.

Bulgaria

Tolerance: Medium
CBD derived from industrial hemp (<0.2% THC) is legal if compliant with labelling and quality standards.
Food, oil, and cosmetic CBD products are widely distributed.

Greece

Tolerance: Medium
Authorities tolerate low-THC CBD flower and oil sales.
Products are subject to tobacco tax (34%) and may only be sold in licensed outlets, similar to Austria’s framework.

North Macedonia

Tolerance: Medium
CBD extracts and oils under 0.2% THC are classified as OTC medicines and sold in pharmacies.

Cyprus

Tolerance: Low
CBD is classified as a medicinal product requiring marketing authorisation.
Raids on unlicensed stores were conducted in January 2025.

Lithuania

Tolerance: Low
CBD in food remains Novel Food restricted.
Cosmetics exist in a grey zone, with frequent recalls.
CBD smoking products may not contain any THC.

Latvia

Tolerance: Medium
Only THC-free CBD cosmetics are permitted officially, but retail stores sell oils, supplements, and flowers informally.

Estonia

Tolerance: Medium
CBD vapes, flowers, and cosmetics are sold, but food supplements require Novel Food approval.
E-liquids may contain <0.2% THC under Tobacco Act regulations.

Finland

Tolerance: Low
CBD ingestibles are banned; only cosmetics and skincare are allowed.
CBD in e-liquids is not approved. Customs regularly seizes CBD shipments.

Sweden

Tolerance: Low
Any CBD product containing THC is a narcotic.
CBD ingestibles are Novel Food restricted.

Norway

Tolerance: Low
Naturally derived CBD is classified as a narcotic; only synthetic CBD is permitted for cosmetic use.

Regional Summary: 2025

Tolerance LevelMarkets
Very HighSwitzerland, Czech Republic
HighUnited Kingdom, Austria, Luxembourg
MediumSpain, France, Belgium, Netherlands, Germany, Denmark, Malta, Poland, Hungary, Croatia, Romania, Bulgaria, Greece, North Macedonia, Latvia, Estonia
LowIreland, Portugal, Italy, Slovenia, Slovakia, Cyprus, Lithuania, Finland, Sweden, Norway
Recent posts
December 18, 2025
Glossary – PSYCH: The Psychedelics As Medicine Report 3rd Edition
December 18, 2025
Psychedelic Research: Clinical Trials, Timelines, and Key Research Groups – PSYCH: The Psychedelics As Medicine Report 3rd Edition
December 18, 2025
Therapy Practitioners in Psychedelic-Assisted Therapy – PSYCH: The Psychedelics As Medicine Report 3rd Edition
December 18, 2025
Patents and Intellectual Property in Psychedelic Medicine – PSYCH: The Psychedelics As Medicine Report 3rd Edition

Catch up on our newest articles that you might have missed

hassaan-here-9jDKSqpqFsw-unsplash
December 18, 2025
Glossary – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...
louis-reed-pwcKF7L4-no-unsplash (1)
December 18, 2025
Psychedelic Research: Clinical Trials, Timelines, and Key Research Groups – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...
stephen-isaiah-nHOIBmZ9Gkw-unsplash
December 18, 2025
Therapy Practitioners in Psychedelic-Assisted Therapy – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...
scott-graham-OQMZwNd3ThU-unsplash
December 18, 2025
Patents and Intellectual Property in Psychedelic Medicine – PSYCH: The Psychedelics As Medicine Report 3rd Edition
Report Contents Jump to any section in the series Introduction → Definitions And Scope → Executive Summary → Key Trends...

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact